Evidence map›Paper›PMID 32324784›Full record

ArticlePloS one2020

Interaction between Mas1 and AT1RA contributes to enhancement of skeletal muscle angiogenesis by angiotensin-(1-7) in Dahl salt-sensitive rats.

Eric C Exner, Aron M Geurts, Brian R Hoffmann, Marc Casati, Timothy Stodola, Nikita R Dsouza, Michael Zimmermann, Julian H Lombard, Andrew S Greene

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19.Clinical science (London, England : 1979) · 2020
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Eric C ExnerDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.ORCID 0000-0003-0129-5536
Aron M GeurtsDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Brian R HoffmannDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Marc CasatiCardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Timothy StodolaDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Nikita R DsouzaGenomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Michael ZimmermannGenomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Julian H LombardDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Andrew S GreeneThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Medical College of Wisconsin · USJackson Laboratory · USMarquette University · US

Funding

Therapeutic Effects of mTOR Inhibition in Salt-Sensitive HypertensionP01HL116264 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI MATTSON, DAVID L. · 2013 to 2021
$18.7M
INTEGRATED PHYSIOLOGY TRAINING--MOLECULE TO ORGANISMT32HL007852 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Matthew Robert Hodges · 1996 to 2026
$6.5M
Medical Scientist Training ProgramT32GM080202 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI BARBIERI, JOSEPH T, SALZMAN, NITA H · 2010 to 2024
$5.7M
MicroRNA-29b and Endothelial FunctionR01HL125409 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LIANG, MINGYU, WIDLANSKY, MICHAEL E · 2015 to 2018
$2.0M
Role of Nrf2 in Vascular Antioxidant DefenseR01HL128242 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LOMBARD, JULIAN H · 2016 to 2019
$1.8M
Evaluation of Endothelial Hyperglycemia-Driven Alterations During Type 2 DiabetesK01DK105043 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI HOFFMANN, BRIAN ROBERT · 2015 to 2018
$407k
Development of Mas Receptor Knockout Rat ResourceR21OD024781 · OD · MEDICAL COLLEGE OF WISCONSIN · PI LOMBARD, JULIAN H · 2017 to 2018
$402k
Medhanism of EPC Dysfunction in the SS Rat: Quantity over QualityF30HL131153 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI EXNER, ERIC C · 2016 to 2019
$181k
NHLBI NIH HHS F30 HL131153NHLBI NIH HHS P01 HL116264NHLBI NIH HHS R01 HL125409NHLBI NIH HHS R01 HL128242NHLBI NIH HHS T32 HL007852NIDDK NIH HHS K01 DK105043NIGMS NIH HHS T32 GM080202NIH HHS R21 OD024781
6 · The paper itself

Abstract

The heptapeptide angiotensin-(1-7) (Ang-(1-7)) is protective in the cardiovascular system through its induction of vasodilator production and angiogenesis. Despite acting antagonistically to the effects of elevated, pathophysiological levels of angiotensin II (AngII), recent evidence has identified convergent and beneficial effects of low levels of both Ang-(1-7) and AngII. Previous work identified the AngII receptor type I (AT1R) as a component of the protein complex formed when Ang-(1-7) binds its receptor, Mas1. Importantly, pharmacological blockade of AT1R did not alter the effects of Ang-(1-7). Here, we use a novel mutation of AT1RA in the Dahl salt-sensitive (SS) rat to test the hypothesis that interaction between Mas1 and AT1R contributes to proangiogenic Ang-(1-7) signaling. In a model of hind limb angiogenesis induced by electrical stimulation, we find that the restoration of skeletal muscle angiogenesis in SS rats by Ang-(1-7) infusion is impaired in AT1RA knockout rats. Enhancement of endothelial cell (EC) tube formation capacity by Ang-(1-7) is similarly blunted in AT1RA mutant ECs. Transcriptional changes elicited by Ang-(1-7) in SS rat ECs are altered in AT1RA mutant ECs, and tandem mass spectrometry-based proteomics demonstrate that the protein complex formed upon binding of Ang-(1-7) to Mas1 is altered in AT1RA mutant ECs. Together, these data support the hypothesis that interaction between AT1R and Mas1 contributes to proangiogenic Ang-(1-7) signaling.

Indexed as

Angiotensin IAnimalsElectric StimulationMaleMass SpectrometryModels, AnimalMuscle, SkeletalMutationNeovascularization, PhysiologicPeptide FragmentsProteomicsProto-Oncogene MasProto-Oncogene ProteinsRatsRats, Inbred DahlReceptor, Angiotensin, Type 1Agtr1a protein, ratAngiotensin Iangiotensin I (1-7)Mas1 protein, ratPeptide FragmentsProto-Oncogene MasProto-Oncogene ProteinsReceptor, Angiotensin, Type 1Receptors, G-Protein-Coupled

Identifiers

PMID32324784
PMCPMC7179868
OpenAlexW3018974225

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.